http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4859674-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6e2ebfcf2ba03f4bda3c77fc77f645c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 1988-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e6af03185dd0f0ffe47fd731e38d091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c0d194b8087ef1178849b557fce709d
publicationDate 1989-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4859674-A
titleOfInvention Pyrazine in prevention and treatment of strokes
abstract Neurologic dysfunction resulting from stroke is diminished by administering to a patient an effective amount of a tetra-substituted pyrazine over a relatively continuous regimen. Conveniently, an initial bolus is administered to bring the level of the drug up to a pre-determined blood level, followed by continuous infusion employing a pump or by continuous intravenous infusion.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10604467-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364202-B2
priorityDate 1987-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229835221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68815462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127852289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129143706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54226752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129019136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128514850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136326756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174

Total number of triples: 40.